Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies

Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Citterio, Chiara, Lazzaro, Antonio, Bosi, Costanza, De Ponzio, Maurice, Cavanna, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190583/
https://www.ncbi.nlm.nih.gov/pubmed/34136224
http://dx.doi.org/10.1002/ccr3.4013
_version_ 1783705714373427200
author Citterio, Chiara
Lazzaro, Antonio
Bosi, Costanza
De Ponzio, Maurice
Cavanna, Luigi
author_facet Citterio, Chiara
Lazzaro, Antonio
Bosi, Costanza
De Ponzio, Maurice
Cavanna, Luigi
author_sort Citterio, Chiara
collection PubMed
description Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients.
format Online
Article
Text
id pubmed-8190583
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81905832021-06-15 Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies Citterio, Chiara Lazzaro, Antonio Bosi, Costanza De Ponzio, Maurice Cavanna, Luigi Clin Case Rep Case Reports Patients with hematological cancer are at major risk of developing infectious complication. The prevention and treatment of COVID‐19 in these patients is challenging. This experience, with the limitation of a small number of patients, highlights that early treatment of COVID‐19 can overcome the infection, also in hematological patients. John Wiley and Sons Inc. 2021-06-10 /pmc/articles/PMC8190583/ /pubmed/34136224 http://dx.doi.org/10.1002/ccr3.4013 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Citterio, Chiara
Lazzaro, Antonio
Bosi, Costanza
De Ponzio, Maurice
Cavanna, Luigi
Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
title Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
title_full Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
title_fullStr Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
title_full_unstemmed Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
title_short Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies
title_sort characteristics and outcomes of five patients with covid‐19 and hematological malignancies
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190583/
https://www.ncbi.nlm.nih.gov/pubmed/34136224
http://dx.doi.org/10.1002/ccr3.4013
work_keys_str_mv AT citteriochiara characteristicsandoutcomesoffivepatientswithcovid19andhematologicalmalignancies
AT lazzaroantonio characteristicsandoutcomesoffivepatientswithcovid19andhematologicalmalignancies
AT bosicostanza characteristicsandoutcomesoffivepatientswithcovid19andhematologicalmalignancies
AT deponziomaurice characteristicsandoutcomesoffivepatientswithcovid19andhematologicalmalignancies
AT cavannaluigi characteristicsandoutcomesoffivepatientswithcovid19andhematologicalmalignancies

Ejemplares similares